ZHEJIANG BAMBOO PHARMACEUTICALS CO., LTD

Zhejiang bamboo Pharmaceutical Co., Ltd. is located in Hangzhou Bay Shangyu national economic and Technological Development Zone. It is a company that produces APIs, preparations, pharmaceutical intermediates and food additives. The total investment of the company's project is 1.05 billion yuan. The first phase of the project will be put into operation in June 2021. It is planned that the annual sales of the first phase of the project will be about 1 billion yuan after all the projects are put into normal operation. The company is positioned as a modern high-end pharmaceutical enterprise integrated with APIs. The finished drugs are mainly sold to the domestic market, aiming to become the largest supplier of national "4 + 7" volume procurement; in addition to ensuring the company's preparation production needs, most of the APIs are exported to the high-end markets in Europe and America, and the products reach the operation and production of the whole industrial chain. At present, our plant construction firmly follows the principle of "pay attention to progress, ensure safety, high quality and control cost", carries forward the enterprise spirit of "bamboo rooted, solid foundation", and advances our project construction efficiently, rapidly and orderly according to the progress. The company now has excellent product varieties, mature technology, and a management team that has been engaged in drug production and sales in high-quality famous pharmaceutical enterprises for nearly 20 years. The company welcomes talents with entrepreneurship, ambition and ambition to join our team to work together to create brilliance. Products and services: preparations, API, intermediates, food additives and CMO. EU GMP and US FDA approval API manufacturer (benzocaine/gabapentin/pregabalin/tranexamic acid/levocarnitine) Benzocaine US DMF NO.:037482; Gabapentin US DMF NO.:037761, pregabalin US DMF no.:038102, Levocarnitine US DMF NO.:039375; Tranexamic acid US DMF NO.:041407 Benzocaine CEP certificate NO.:CEP 2022-395-Rev01 Gabpentin CEP certificate NO.:CEP 2023-027-Rev02 Pregabalin CEP certificate NO.:CEP 2023-183 - Rev00 Levocarnitine CEP application NO.:2025-034 Etodolac CEP application NO.:CEP 2025-257 Tranexamic acid CEP application NO.:CEP 2025-258